BioCentury
ARTICLE | Company News

Biacore AB, Bioreason deal

September 20, 1999 7:00 AM UTC

The companies will develop software and biosensor assay systems for drug absorption, distribution, metabolism and excretion (ADME) screening. BCOR will invest $900,000 in Bioreason equity to obtain a minority stake, and the companies will share development costs and split revenues. ...